We are live on
!
Find out more
Mirae Asset Global Investments Portfolio holdings
AUM
$67.7B
1-Year Est. Return
57.61%
This Fund
S&P 500
This Quarter
Est. Return
+4.4%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$24.6B
AUM Growth
+$2.03B
(+9%)
Cap. Flow
+$1.28B
Cap. Flow
% of AUM
5.2%
Top 10 Holdings %
Top 10 Hldgs %
38.38%
Holding
1,702
New
151
Increased
731
Reduced
674
Closed
110
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$167M |
| 2 |
Apple
AAPL
|
+$66M |
| 3 |
Microsoft
MSFT
|
+$57.3M |
| 4 |
HDFC Bank
HDB
|
+$44M |
| 5 |
Schwab US Dividend Equity ETF
SCHD
|
+$41.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$81.5M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$81.3M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$45.8M |
| 4 |
Advanced Micro Devices
AMD
|
+$43.4M |
| 5 |
Meta Platforms (Facebook)
META
|
+$35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.15% |
| 2 | Consumer Discretionary | 10.25% |
| 3 | Communication Services | 8.94% |
| 4 | Healthcare | 6.61% |
| 5 | Financials | 5.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Pliant Therapeutics
PLRX
$67.5M
| $27.5K | ﹤0.01% |
2,028
-171
| -8% | -$2.33K |
|
1377
Under Armour
UAA
$2.3B
| $27.5K | ﹤0.01% |
+3,277
| New | +$29.9K |
|
1378
Paylocity
PCTY
$7.72B
| $27.4K | ﹤0.01% |
137
-81
| -37% | -$15.5K |
|
1379
Prothena Corp
PRTA
$474M
| $27.1K | ﹤0.01% |
1,793
-152
| -8% | -$2.4K |
|
1380
Companhia Siderúrgica Nacional
SID
$1.17B
| $27.1K | ﹤0.01% |
18,696
-664
| -3% | -$1.3K |
|
|
MOMO
1381
Hello Group
MOMO
$857M
| $27.1K | ﹤0.01% |
3,714
-379
| -9% | -$2.69K |
|
|
NXRT
1382
NexPoint Residential Trust
NXRT
$643M
| $26.6K | ﹤0.01% |
638
-262
| -29% | -$11.6K |
|
|
BDN
1383
Brandywine Realty Trust
BDN
$548M
| $26.6K | ﹤0.01% |
4,819
-1,868
| -28% | -$10.4K |
|
1384
Lincoln Electric
LECO
$15.3B
| $26.2K | ﹤0.01% |
138
-84
| -38% | -$16.9K |
|
1385
Tetra Tech
TTEK
$9.03B
| $26.2K | ﹤0.01% |
657
-393
| -37% | -$17.6K |
|
1386
Maravai LifeSciences
MRVI
$870M
| $26K | ﹤0.01% |
4,727
-393
| -8% | -$2.53K |
|
1387
Castle Biosciences
CSTL
$966M
| $25K | ﹤0.01% |
933
-70
| -7% | -$2.13K |
|
1388
Woodward
WWD
$21.2B
| $24.6K | ﹤0.01% |
145
-89
| -38% | -$15.2K |
|
1389
Weibo
WB
$1.88B
| $24.6K | ﹤0.01% |
2,574
-91
| -3% | -$871 |
|
1390
Relay Therapeutics
RLAY
$4.44B
| $24.3K | ﹤0.01% |
5,578
+735
| +15% | +$4K |
|
1391
Aaon
AAON
$7.43B
| $24.2K | ﹤0.01% |
+199
| New | +$24.4K |
|
|
SAFE
1392
Safehold
SAFE
$1.1B
| $24.1K | ﹤0.01% |
1,296
-506
| -28% | -$11K |
|
1393
Erasca
ERAS
$6.37B
| $23.9K | ﹤0.01% |
9,421
-797
| -8% | -$2.19K |
|
1394
Ironwood Pharmaceuticals
IRWD
$681M
| $23.7K | ﹤0.01% |
5,333
-444
| -8% | -$1.8K |
|
1395
Tyra Biosciences
TYRA
$1.5B
| $23.7K | ﹤0.01% |
+1,686
| New | +$30.6K |
|
|
CVAC
1396
DELISTED
CureVac
CVAC
| $23.7K | ﹤0.01% |
7,476
-637
| -8% | -$1.84K |
|
1397
Humacyte
HUMA
$170M
| $23.6K | ﹤0.01% |
4,288
-29
| -0.7% | -$143 |
|
|
PGRE
1398
DELISTED
Paramount Group
PGRE
| $23.5K | ﹤0.01% |
4,855
-1,893
| -28% | -$9.36K |
|
1399
Evolus
EOLS
$544M
| $23.4K | ﹤0.01% |
2,110
-172
| -8% | -$2.42K |
|
1400
Cullinan Oncology
CGEM
$1.27B
| $23.3K | ﹤0.01% |
1,940
-157
| -7% | -$2.26K |
|
Similar funds
Mirae Asset Global Investments's Q4 2024 Portfolio in Review
As of Q4 2024, Mirae Asset Global Investments held 1,702 positions worth $24.6B, up 9% from $22.6B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Mirae Asset Global Investments deployed $1.28B of net new capital in Q4 2024, opening 151 new positions and adding to 731 existing holdings. Its largest new stake was Strategy Inc: 36,162 shares worth $11.8M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $81.5M trimmed.
- Mirae Asset Global Investments's largest Q4 2024 buy was Strategy Inc: 36,162 shares worth $11.8M.
- Mirae Asset Global Investments added most to Vanguard S&P 500 ETF in Q4 2024, an estimated $167M increase.
- Mirae Asset Global Investments's biggest Q4 2024 reduction was Invesco QQQ Trust, cutting an estimated $81.5M.
- Mirae Asset Global Investments fully exited VanEck Pharmaceutical ETF in Q4 2024, selling an estimated $23.6M.
- Mirae Asset Global Investments's ten largest holdings make up 38% of its $24.6B portfolio in Q4 2024.
- Mirae Asset Global Investments opened 151 new positions and closed 110 in Q4 2024.
- Mirae Asset Global Investments's portfolio value rose 9% quarter-over-quarter to $24.6B.
Based on Mirae Asset Global Investments's 13F filing for Q4 2024, filed 27 Jan 2025.